Cargando…

I-SPY 2: optimising cancer drug development in the 21st century

Detalles Bibliográficos
Autores principales: Bartsch, Rupert, de Azambuja, Evandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115814/
https://www.ncbi.nlm.nih.gov/pubmed/27900209
http://dx.doi.org/10.1136/esmoopen-2016-000113
_version_ 1782468576071909376
author Bartsch, Rupert
de Azambuja, Evandro
author_facet Bartsch, Rupert
de Azambuja, Evandro
author_sort Bartsch, Rupert
collection PubMed
description
format Online
Article
Text
id pubmed-5115814
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51158142016-11-29 I-SPY 2: optimising cancer drug development in the 21st century Bartsch, Rupert de Azambuja, Evandro ESMO Open Editorial BMJ Publishing Group 2016-11-15 /pmc/articles/PMC5115814/ /pubmed/27900209 http://dx.doi.org/10.1136/esmoopen-2016-000113 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Editorial
Bartsch, Rupert
de Azambuja, Evandro
I-SPY 2: optimising cancer drug development in the 21st century
title I-SPY 2: optimising cancer drug development in the 21st century
title_full I-SPY 2: optimising cancer drug development in the 21st century
title_fullStr I-SPY 2: optimising cancer drug development in the 21st century
title_full_unstemmed I-SPY 2: optimising cancer drug development in the 21st century
title_short I-SPY 2: optimising cancer drug development in the 21st century
title_sort i-spy 2: optimising cancer drug development in the 21st century
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115814/
https://www.ncbi.nlm.nih.gov/pubmed/27900209
http://dx.doi.org/10.1136/esmoopen-2016-000113
work_keys_str_mv AT bartschrupert ispy2optimisingcancerdrugdevelopmentinthe21stcentury
AT deazambujaevandro ispy2optimisingcancerdrugdevelopmentinthe21stcentury